963 Stock Overview
Huadong Medicine Co., Ltd produces and sells various pharmaceutical products in China.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Huadong Medicine Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥31.02 |
52 Week High | CN¥49.57 |
52 Week Low | CN¥27.60 |
Beta | 0.70 |
1 Month Change | -6.17% |
3 Month Change | -21.13% |
1 Year Change | -31.96% |
3 Year Change | -15.84% |
5 Year Change | 11.65% |
Change since IPO | 694.87% |
Recent News & Updates
Shareholder Returns
963 | CN Healthcare | CN Market | |
---|---|---|---|
7D | -7.0% | -5.8% | -2.9% |
1Y | -32.0% | -30.3% | -15.4% |
Return vs Industry: 000963 underperformed the CN Healthcare industry which returned -30.3% over the past year.
Return vs Market: 000963 underperformed the CN Market which returned -15.4% over the past year.
Price Volatility
963 volatility | |
---|---|
963 Average Weekly Movement | 5.4% |
Healthcare Industry Average Movement | 6.7% |
Market Average Movement | 8.1% |
10% most volatile stocks in CN Market | 11.3% |
10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 000963's share price has been volatile over the past 3 months.
Volatility Over Time: 000963's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | 14,061 | n/a | https://www.eastchinapharm.com |
Huadong Medicine Co., Ltd produces and sells various pharmaceutical products in China. It also engages in the production and management of traditional Chinese and western raw medicines and preparations, and health care products; wholesale of TCM materials, TCM decoction pieces, chemical preparations, etc.; warehousing and storage business; and research, development, production, and sale of aesthetic medicine products. Huadong Medicine Co., Ltd was founded in 1993 and is headquartered in Hangzhou, China.
Huadong Medicine Co., Ltd Fundamentals Summary
963 fundamental statistics | |
---|---|
Market cap | CN¥54.55b |
Earnings (TTM) | CN¥2.71b |
Revenue (TTM) | CN¥40.25b |
20.1x
P/E Ratio1.3x
P/S RatioIs 963 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
963 income statement (TTM) | |
---|---|
Revenue | CN¥40.25b |
Cost of Revenue | CN¥27.39b |
Gross Profit | CN¥12.86b |
Other Expenses | CN¥10.15b |
Earnings | CN¥2.71b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 18, 2024
Earnings per share (EPS) | 1.55 |
Gross Margin | 31.95% |
Net Profit Margin | 6.72% |
Debt/Equity Ratio | 7.4% |
How did 963 perform over the long term?
See historical performance and comparison